Connective tissue growth factor is associated with a stable atherosclerotic plaque phenotype and is involved in plaque stabilization after stroke

Stroke

Volumn 41, Issue 12, 2010, Pages 2979-2981

  Leeuwis, Jan Willem ^a   Nguyen, Tri Q ^a   Theunissen, Maarten G J ^a   Peeters, Wouter ^a   Goldschmeding, Roel ^a   Pasterkamp, Gerard ^a   Vink, Aryan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

atherosclerosis; carotid endarterectomy; plaque stability

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; LIPID; NEUTROPHIL COLLAGENASE;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STROKE; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL PROLIFERATION; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; ENDARTERECTOMY, CAROTID; EXTRACELLULAR MATRIX; FEMALE; HUMANS; INTERLEUKINS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; STROKE;

EID: 78650416922     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.589036     Document Type: Article

References (10)

1. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: Evolving concepts. J Am Coll Cardiol. 2005;46:937-954.
2. Peeters W, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Vink A, Pasterkamp G. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol. 2009;29:128-133.
3. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320-2328.
4. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-1852.
5. Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol. 2002;21:473-482.
6. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M, März W, Rupp J, Pech M, Lüscher TF. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 1997;95: 831-839.
7. Verhoeven BA, Velema E, Schoneveld AH, de Vries JP, de Bruin P, Seldenrijk CA, de Kleijn DP, Busser E, Van Der Graaf Y, Moll F, Pasterkamp G. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol. 2004;19: 1127-1133.
8. Moussad EE, Brigstock DR. Connective tissue growth factor: what's in a name? Mol Genet Metab. 2000;71:276-292.
9. Sluijter JP, Pulskens WP, Schoneveld AH, Velema E, Strijder CF, Moll F, de Vries JP, Verheijen J, Hanemaaijer R, de Kleijn DP, Pasterkamp G. Matrix metalloproteinase 2 is associated with stable and matrix metallo-proteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke. 2006;37:235-239.
10. Nguyen TQ, Roestenberg P, Van Nieuwenhoven FA, Bovenschen N, Li Z, Xu L, Oliver N, Aten J, Joles JA, Vial C, Brandan E, Lyons KM, Goldschmeding R. CTGF inhibits BMP-7 signaling in diabetic nephrop-athy. J Am Soc Nephrol. 2008;19:2098-2107.